Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 1998

View Archived Issues

Antipsoriatic dihydrofolate reductase inhibitors available for licensing from BTG

Long-term use of salmeterol for exercise-induced asthma results in decreased duration of action

Hokuriku designs potent, orally active, metabolically stable TxA2/CysLT1 antagonists

Erythromycins from Taisho for Gram-positive infections

Morinaga Milk develops peptides with antifungal activity

Benzodiazepine omega3 receptor ligands with anxiolytic, anticonvulsant and antiarthritic effects

Mer-WF-1726: new antitumor substance isolated from natural source

Spotlight on sigma-receptors as a target for intervention in CNS disorders

Cell Therapeutics licenses rights to PG-TXL

Icos begins phase II multiple-dose trial in multiple sclerosis patients

Kos files European marketing application for Niaspan and begins clinical trials with Nicostatin

Analgesic effects of dosulepin in patients with cancer-related pain

GV-150013 has dual therapeutic potential in treating alcoholism and sleep disorders

Vigabatrin is effective for treating alcohol withdrawal syndrome

Preclinical results point to anxiolytic efficacy for Yoshitomi benzodiazepine

SomatoKine progresses to phase II for a new disease indication

Lisofylline development timetable readjusted, marketing agreements revised

Scientists report success in achieving tolerance in transplantation models

L-054264, the first small-molecule sst2 receptor agonist reported

Inhibitors of iNOS described by Ono scientists

FDA clears SSRI for depression

Oncologic Drugs Advisory Committee meets for three days in September

Patient dosing begins in phase Ib trial of stroke drug from NPS

Roche to sell participation in DePuy

Neurogen's epilepsy compound advances through clinical trials

Sepracor and Janssen sign licensing agreement for cisapride metabolite

French and Israeli researchers synthesize peptides active against slow-growing, anaerobic bacteria

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...